Adelphi Real World
  • Home
  • DSPs
    • Autoimmune
    • Oncology
    • Rare Disease
    • CVRM-L
    • CNS
    • Respiratory
    • Women’s Health
    • Ophthalmology
    • Infectious Disease
  • Observational Research
  • Database Study Design
  • Therapy Experience
    • Autoimmune
    • Oncology
    • Rare Disease
    • CVRM-L
    • CNS
    • Respiratory
    • Women’s Health
    • Ophthalmology
    • Infectious Disease
  • Latest Thoughts
    • Our Science
    • Our Real World Reach
    • Our Innovations
  • Publications
  • Contact us
Select Page

Understanding Rare Diseases Through Real-World Data

by Rosie Rodman | Feb 23, 2026 | Uncategorized

Due to the nature of rare diseases, real-world data are often required to characterise and understand the experiences of these patient groups and their families. Rare diseases are often complex and present a number of challenges in terms of diagnosis, management and...

Advancing Care in Movement Disorders Through Real-World Evidence

by Rosie Rodman | Feb 23, 2026 | Uncategorized

Movement disorders – including Essential Tremor, Huntington’s Disease, Parkinson’s Disease, Spasticity, and Progressive Supranuclear Palsy (PSP) – demand sophisticated understanding of disease progression, treatment complexity, motor symptom management,...

Advancing Care in Neuroimmune Disorders Through Real-World Evidence

by Rosie Rodman | Feb 23, 2026 | Uncategorized

Neuroimmune disorders – including CIDP, Multiple Sclerosis, NMO, and Guillain-Barré Syndrome (GBS), MOGAD – demand sophisticated understanding of disease progression, treatment complexity, symptom management, and patient outcomes across diverse care...

Advancing Care in Seizure Disorders Through Real-World Evidence

by Rosie Rodman | Feb 23, 2026 | Uncategorized

Seizure disorders – including Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS), and other complex epilepsies – demand sophisticated understanding of disease presentation, treatment complexity, seizure control, patient outcomes, and caregiver burden...

Advancing Care in Migraine Through Real-World Evidence

by Rosie Rodman | Feb 23, 2026 | Uncategorized

Migraine is a disabling neurological condition characterised by recurrent attacks of headache pain, and requires a sophisticated understanding of disease progression, treatment complexity, attack frequency, and patient outcomes across diverse care settings. As the...
« Older Entries

CONTACT US

If you would like to learn more about Adelphi Real World, please complete the form and a member of the Client Service Team will be in touch with you shortly.

Adelphi Real World | Headquarters Address: Adelphi Mill, Bollington, Cheshire, SK10 5JB
Tel: +44 1625 577233 | Fax: +44 1625 575853 | Contact Us
Privacy Policy | Cookie Notice | NHS Privacy Notice | Recruitment Privacy Notice | California Consumer Privacy Statement | Terms & Conditions
Do not reproduce without permission. An Omnicom Group Inc Company
Company Reg No: 1975338
Registered Office: Bankside 3 90-100 Southwark St, London SE1 0SW
© 2025 Adelphi Group | Designed by Embrace Marketing Ltd
Manage Cookie Consent

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary Always active
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Analytics
We’d like to set analytic software i.e. Google Analytics/Click Dimensions to help us improve our website by collecting and reporting information on how you use it. The cookies collect information in a way that does not directly identify anyone. For more information on how these cookies work, please see our Cookies Policy. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
  • About WordPress
    • WordPress.org
    • Documentation
    • Learn WordPress
    • Support
    • Feedback